KRINGLE PHARMA
DEAD

Serial Number

86028683

Owner

Kringle Pharma, Inc.

Attorney

Sarah G. Voeller

Filing Date

Aug 5, 2013

Add to watchlist:

No watchlists yet
View on USPTO

KRINGLE PHARMA Trademark

Serial Number: 86028683 • Registration: 4545413

KRINGLE PHARMA is a trademark filed by Kringle Pharma, Inc. on August 5, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Kringle Pharma, Inc. (12 trademarks)

Senri Asahi Hankyu Bldg. 8F 5-3
Osaka 560-0082 , JP

Entity Type: 03

Trademark Details

Filing Date

August 5, 2013

Registration Date

June 3, 2014

Cancellation Date

June 5, 2020

Goods & Services

Pharmaceutical, veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; Sanitary preparations for medical use; Central nervous system stimulants; Hair growth stimulant; Antipyretic analgesics; Anti-epileptics; Analeptics; Hypnotic sedatives; General anesthetics; Anti-motion sickness preparations; Pharmaceutical preparations acting on the peripheral nervous system; Local anesthetics; Skeletal muscle relaxants; Anhidrotics; Autonomics; Antispasmodics; Diaphoretics; Pharmaceutical preparations acting on the sensory organs; Ophthalmic preparations; Agents for otic and nasal use, namely, nasal spray preparations, eye washes, eye drops, irrigating solutions for eye use; Treatment for eye infection, macular degeneration, retinopathy, rhinitis, and sinusitis; Pharmaceutical antiallergic preparations; Antihistaminics; Cardiovascular treatment preparations; Cardiotonics; Antihypertensives; Vasoconstrictors; Capillary stabilizers; Cerebral hemorrhage prophylactic preparations; Antiarrhythmic preparations; Diuretics; Pharmaceutical preparations acting on respiratory organs; Respiratory stimulants; Anti-cough drops; Antitussive expectorants; Pharmaceutical preparations acting on digestive organs; Gastrointestinal cleaning agents; Clysters; Evacuants (purgatives); Stomachics and digestives; Pharmaceutical preparations for oral use, and for oral inflammation; Emetics; Pharmaceutical preparations for dental purposes for gingivostomatitis, alveolar abscess, and alveoloclasia; Antacids; Antiemetics; Castor oil for medical purposes; Cholagogues; Hormones for medical purposes; Thyroid and para-thyroid hormone preparations; Mixed hormone preparations; Estrogen preparations; Pancreas hormone preparations; Salivary gland hormone preparations; Androgen preparations; Pituitary hormone preparations; Adrenal hormone preparations; Pharmaceutical preparations acting on uro-genital and anal organs; Oxytocics; Anti-hemorrhoidals; Emmenagogues; Contraceptives; Medicated skin care preparations; Pharmaceutical preparations for purulence; Anti-dermoinfectives; Antimicrobials for dermatologic use; Astringents; Anti-inflammatory agents; Analgesics; Anti-itchings; Talcum powder for medical purposes; Medicated baby oils; Medicated baby powders; Medicated bath preparations; Vitamin preparations for medical purposes; Cod-liver oil drops for medical purposes; Mixed vitamin preparations for medical purposes; Vitamin A preparations for medical purposes; Vitamin C preparations for medical purposes; Vitamin D preparations for medical purposes; Vitamin B preparations for medical purposes; Multi-vitamin preparations for medical purposes; Amino acid preparations for medical purposes; Threonine preparations; Tryptophane preparations; Methionine preparations; Lysine preparations; Royal jelly for medical purposes; Calcium supplements for medical purposes; Chondroitin preparations for medical purposes; Protein and amino acid preparations for medical purposes; Saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; Mineral preparations for medical use; Anticoagulants; Blood substitutes for human and veterinary use; Blood plasma; Hemostatics; Pharmaceutical preparations affecting metabolism; Antidotes; Enzyme preparations for medical purposes; Lactagogues; Lipotropic factor preparations; Pharmaceutical preparations for the treatment of habitual intoxication; Pharmaceutical preparations for activating cellular function; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical preparations for treating physically caused lesions; Pharmaceutical preparations for treating heatstroke; Radiation sickness treating drugs; Pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn, side effect of anticancer drugs, and immunosuppresants; Chlorine-detoxication preparations; Arsenic-detoxication preparations; Benzol-detoxication preparations; Antibiotic preparations; Erythromycin preparations; Chloramphenicol preparations; Colistin-polymixin preparations; Sarkomycin preparations; Streptomycin preparations; Thiolutin preparations; Tetracycline preparations; Trichomycin preparations; Mixed antibiotic preparations; Penicillin preparations; Chemotherapeutics; Antisyphilitics; Antituberculous preparations; Sulfonamide preparations; Antileprotic preparations; Biological preparations for medical purposes; Antitoxic sera; Antitoxins; Mixed biological preparations for medical purposes; Preparations for biological tests for medical purposes; Toxoids; Vaccines; Preparations for destroying parasites; Anthelmintics; Odor neutralizing preparations for use on drugs; Pharmaceutical excipients; Diagnostic preparations for medical use; X-ray contrast agents; Diagnostic reagents for medical use; Diagnostic media for bacteriological cultures for medical use; Radio isotope markers for therapeutic or diagnostic use; Opium alkaloid preparations; Synthetic narcotics; Coca alkaloid preparations; Mosquito-repellent incenses; Germicides and fungicides; Rodenticides; Insecticides; Fumigants; Herbicides, namely, weedkillers; Insect-repellents; Antiseptics

Testing, inspection or research of pharmaceuticals and genetics; Medical research; Consultancy and providing information services in the field of testing, inspection or research of pharmaceuticals and genetics; Consultancy and providing information services in the field of medical research; Providing medical and scientific research information and advice in the fields of pharmaceuticals and genetics

Filing History

NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Jun 6, 2020 NCS7
CANCELLED SECTION 7-TOTAL
Jun 5, 2020 C7..
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 4, 2020 APRE
REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Apr 30, 2020 C7RF
TEAS SECTION 7 SURRENDER RECEIVED
Apr 30, 2020 ES7S
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 29, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 29, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 29, 2020 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 29, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 29, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 29, 2020 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 3, 2019 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 2, 2016 TCCA
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 21, 2014 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 21, 2014 APRE
TEAS SECTION 7 REQUEST RECEIVED
Nov 11, 2014 ES7R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 11, 2014 TCCA
REGISTERED-SUPPLEMENTAL REGISTER
Jun 3, 2014 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 28, 2014 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 25, 2014 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2014 CRFA
ASSIGNED TO LIE
Apr 14, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 21, 2013 GNRN
NON-FINAL ACTION E-MAILED
Nov 21, 2013 GNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2013 CNRT
ASSIGNED TO EXAMINER
Nov 19, 2013 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Aug 13, 2013 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2013 NWOS
NEW APPLICATION ENTERED
Aug 8, 2013 NWAP